HER2-negative metastatic breast cancer (MBC) is a common setting in which chemotherapy could be effective even in later lines of treatment. Oral etoposide has demonstrated clinical activity in this setting in small-scale studies, but its efficacy has not been compared to that of other chemotherapy regimens.
-
October 24, 2018 (v1)Journal articleUploaded on: December 4, 2022
-
April 2021 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
February 21, 2019 (v1)Journal article
Purpose The currently ongoing Epidemiological Strategy and Medical Economics (ESME) research programme aims at centralising real-life data on oncology care for epidemiological research purposes. We draw on results from the metastatic breast cancer (MBC) cohort to illustrate the methodology used for data collection in the ESME research...
Uploaded on: December 4, 2022